ICAM1 and atherosclerosis: Thrombin-cleaved PAR1 was associated with increased plasma biomarkers such as VCAM1, ICAM-1, and E-selectin in 190 high-risk patients (CRP of mg/L 7.4 ± 6.7 mean ± SD) with chronic CVD due to atherosclerosis.